🕒 Monday 22 December 2025 Mon, 22 Dec 2025

Regis Healthcare announces the resignation of CEO Dr Linda Mellors after six years, with a transition period underway as the board searches for her successor.

Comet Ridge Limited has obtained federal environmental approval for its Mahalo North natural gas project, paving the way for expanded development in Queensland’s Bowen Basin. This milestone complements recent ownership consolidation and state approvals, positioning the company to boost east coast gas supply.

Waypoint REIT has secured a decade-long lease extension with Viva Energy Australia on 21 sites, boosting rental income by over 12% from August 2026. The REIT also strengthens its financial footing through key refinancing moves.

Western Mines Group reports significant nickel sulphide mineralisation from deep diamond drilling at its Mulga Tank project, reinforcing its vision of a large-scale hybrid nickel system. Drilling will resume in January 2026 to extend these promising results.

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Cyclopharm Limited has secured regulatory approval for its Technegas lung imaging technology in Colombia, marking its presence in 67 countries worldwide. This milestone aligns strategically with the upcoming global nuclear medicine congress in Cartagena.

Clarity Pharmaceuticals has secured positive FDA guidance to initiate a pivotal Phase III trial of its Cu-64 SARTATE diagnostic agent for neuroendocrine tumours, aiming to improve detection and patient outcomes.

Pure One Corporation Limited is set to exit its 40% stake in Turquoise Group for AUD 5 million, securing a substantial profit and refocusing on its core clean energy ventures.

Mithril Silver and Gold accelerates exploration at its Copalquin gold-silver project with a third drill rig mobilized and a 25,000-metre drilling program planned for 2026, targeting multiple high-grade zones.

BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics for US$4.8 billion includes Dimerix’s US licensing agreement, promising significant milestone payments and royalties. This deal strengthens Dimerix’s position as it advances its Phase 3 kidney disease therapy.

IVE Group has agreed to acquire Australian creative agency Daily Press for up to $35 million, bolstering its digital, social, and performance marketing capabilities as part of its ‘Now to 2030’ growth strategy.

Invictus Energy has completed the Petroleum Production Sharing Agreement process for its Cabora Bassa Project, setting the stage for significant gas exploration and development in Zimbabwe.

Lendlease has struck a binding agreement to sell a significant stake in its Malaysian TRX retail and office assets, marking a key step in its FY26 capital recycling strategy aimed at reducing gearing and unlocking value.

Strata Minerals Limited has successfully completed the first tranche of its $1.175 million capital raising, issuing over 55 million shares to investors. The company now awaits shareholder approval to complete the remaining funding.

FlexiRoam has secured a strategic partnership with Generali Insurance Malaysia to deploy its AI-driven eSIM connectivity platform through WhatsApp, targeting the growing travel insurance market.

Aurizon has lodged a proposed ten-year Network Access Undertaking with the Queensland Competition Authority, aiming to secure long-term certainty and enhanced operational incentives for the Central Queensland Coal Network.

DeSoto Resources reports promising initial gold assay results from its maiden drilling program at Dadjan and Tolé in Guinea, highlighting the potential for a large gold system within its extensive landholding.

INOVIQ Limited has reported compelling preclinical results for its CAR-NK-exosome therapy targeting triple-negative breast cancer, showing significant tumor reduction and perfect survival in treated mice.

Rumble Resources reports significant progress at its Western Queen Gold and Tungsten Project, with drilling intersecting key mineralisation and a scoping study revealing robust underground mining economics.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

Ballard Mining has completed an 86,000m infill drilling program at its Baldock gold deposit, delivering strong assay results that support upgrading resources and targeting a maiden Ore Reserve by mid-2026.

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

Meteoric Resources has obtained the Preliminary Environmental Licence without restriction for its Caldeira Rare Earth Ionic Clay Project in Brazil, clearing a key regulatory hurdle and keeping the project on track for mid-2026 construction.

Waratah Minerals reports significant new gold assay results from its Spur Gold Project in New South Wales, revealing promising high-grade mineralisation and growth potential. Ongoing drilling continues to expand the resource footprint with multiple rigs active.